Massive bone marrow infiltration of neuroendocrine carcinoma mimicking aggressive hematological malignancy

被引：0
|
作者：
Satoshi Ichikawa
Kyoko Inokura
Yoshifumi Kawamura
Noriko Fukuhara
Hisayuki Yokoyama
Kota Ouchi
Fumiyoshi Fujishima
Hideo Harigae
机构：
[1] Tohoku University Hospital,Department of Hematology
[2] Tohoku University Hospital,Department of Medical Oncology
[3] Tohoku University Hospital,Department of Pathology
来源：
Journal of Hematopathology | 2021年 / 14卷
关键词：
Bone marrow carcinomatosis; Neuroendocrine carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：337 / 339
页数：2
相关论文
共 50 条
  • [41] HEMATOLOGICAL, BIOCHEMICAL AND BONE-SCAN FINDINGS IN PATIENTS WITH MARROW CARCINOMA
    CAMPBELL, LJ
    VANDERWEYDEN, MB
    PATHOLOGY, 1991, 23 (03) : 198 - 201
  • [42] Diffuse bone marrow metastasis of cancer cells mimicking hematologic malignancy in a case of rhabdomyosarcoma
    Wei, Chao-Hung
    Lin, Chien-Chin
    Lee, Jen-Chieh
    Tien, Hwei-Fang
    EJHAEM, 2021, 2 (01): : 5 - 6
  • [43] What a Predictive Factor of Decreased Cardiac Contractility with Hematological Malignancy after Bone Marrow Transplantation?
    Orihara, Yoshiyuki
    Hirotani, Shinichi
    Ando, Tomotaka
    Mano, Toshiaki
    Ishihara, Masaharu
    Masuyama, Tohru
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S202 - S202
  • [44] Abnormal bone marrow-derived mesenchymal stem cell: Another clone in hematological malignancy?
    Yeh, SP
    Chiu, CF
    Liao, YM
    Lin, CL
    Lo, WJ
    Lee, CC
    BLOOD, 2005, 106 (11) : 404A - 404A
  • [45] Impact of donor lymphocyte infusion for hematological malignancy relapsed after allogeneic bone marrow transplantation
    Zeder, K
    Waller, EK
    Redei, I
    Connaghan, DG
    Fleming, WH
    Geller, RB
    Heffner, LT
    Hillyer, CD
    Holden, J
    Holland, K
    Jones, W
    Mccollum, J
    Mogul, M
    Phillips, C
    Rodey, G
    Wingard, JR
    Winton, E
    Yeager, AM
    Devine, S
    CANCER RESEARCH THERAPY & CONTROL, 1998, 5 (04): : 221 - 228
  • [46] Association of 18FDG Uptake by Bone Marrow and Spleen with Hematological Parameters in Patients with and without Malignancy
    Inoue, K.
    Okada, K.
    Goto, R.
    Taki, Y.
    Kinomura, S.
    Kaneta, T.
    Fukuda, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S260 - S260
  • [47] Down-regulation of antihost alloreactivity after bone marrow transplant permits relapse of hematological malignancy
    Wang, J
    Shaw, JL
    Mullen, CA
    CANCER RESEARCH, 2002, 62 (01) : 208 - 212
  • [48] Bridging the gap: a palliative care consultation service in a hematological malignancy-bone marrow transplant unit
    Selvaggi, Kathy J.
    Vick, Judith B.
    Jessell, Susan A.
    Lister, John
    Abrahm, Janet L.
    Bernacki, Rachelle
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (02): : 50 - 55
  • [49] Allogeneic bone marrow transplantation in patients with hematological malignancy using busulfan, thiotepa, fludarabine as conditioning regimen
    Raiola, A. M.
    Dominietto, A.
    Varaldo, R.
    Gualandi, F.
    Di Grazia, C.
    Lamparelli, T.
    Bregante, S.
    van Lin, M. T.
    Galaverna, F.
    Ghiso, A.
    Marani, C.
    Bacigalupo, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S221 - S221
  • [50] Mediastinal small cell carcinoma with liver and bone marrow metastasis, mimicking lymphoma
    Nawarawong, Napaporn
    Pongpruttipan, Tawatchai
    Aswakul, Pitulak
    Prachayakul, Varayu
    WORLD JOURNAL OF CLINICAL CASES, 2015, 3 (10) : 915 - 919
12345